• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A simple and sensitive HPLC method for determination of gliclazide in human serum.

作者信息

Rouini Mohammad-Reza, Mohajer Afshin, Tahami Mohammad-Hosein

机构信息

Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 14155-6451, Iran.

出版信息

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Mar 5;785(2):383-6. doi: 10.1016/s1570-0232(02)00951-0.

DOI:10.1016/s1570-0232(02)00951-0
PMID:12554153
Abstract

A simple, rapid and specific method for analysis of gliclazide in serum by a sensitive high-performance liquid chromatographic method is described. Only 100 microl of serum and a little sample work-up is required. A simple procedure of extraction by toluene followed by evaporation to dryness under a gentle stream of air and dissolving the dried residue in mobile was used. The gliclazide peak was separated from endogenous peaks on a C(8) column by a mobile phase of acetonitrile-water (45:55, v/v), pH 3. Gliclazide and internal standard (phenytoin) were eluted at 6.8 and 3.8 min, respectively. The limit of quantitation (LOQ) for gliclazide in serum was 75 ng/ml at 230 nm. The method was linear over the range of 75-10,000 ng/ml with r(2) of 0.999. Mean recovery for gliclazide and internal standard was 84.5 and 87%, respectively.

摘要

相似文献

1
A simple and sensitive HPLC method for determination of gliclazide in human serum.
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Mar 5;785(2):383-6. doi: 10.1016/s1570-0232(02)00951-0.
2
Liquid chromatography method for determination of mefenamic acid in human serum.液相色谱法测定人血清中甲芬那酸的含量。
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Feb 5;800(1-2):189-92. doi: 10.1016/j.jchromb.2003.09.063.
3
Determination of gliclazide in serum by high-performance liquid chromatography using solid-phase extraction.
J Chromatogr. 1992 Dec 2;583(2):266-9. doi: 10.1016/0378-4347(92)80563-6.
4
Application of monolithic column in quantification of gliclazide in human plasma by liquid chromatography.整体柱在液相色谱法测定人血浆中格列齐特含量中的应用。
J Pharm Biomed Anal. 2006 Oct 11;42(4):513-6. doi: 10.1016/j.jpba.2006.05.003. Epub 2006 Jun 23.
5
Liquid chromatography--mass spectrometry method for the determination of gliclazide in human plasma and application to a pharmacokinetic study of gliclazide sustained release tablets.
Arzneimittelforschung. 2008;58(12):653-8. doi: 10.1055/s-0031-1296567.
6
High-performance liquid chromatography with electrochemical detection for analysis of gliclazide in plasma.采用电化学检测的高效液相色谱法分析血浆中的格列齐特。
J Chromatogr A. 2005 Sep 23;1088(1-2):131-5. doi: 10.1016/j.chroma.2004.12.097.
7
Comparison of capillary electrophoresis with HPLC for diagnosis of factitious hypoglycemia.毛细管电泳与高效液相色谱法在假性低血糖诊断中的比较。
Clin Chem. 2000 Nov;46(11):1773-80.
8
Nateglinide quantification in rabbit plasma by HPLC: optimization and application to pharmacokinetic study.高效液相色谱法测定兔血浆中那格列奈的含量:方法优化及其在药代动力学研究中的应用
J Pharm Biomed Anal. 2007 May 9;44(1):196-204. doi: 10.1016/j.jpba.2007.02.028. Epub 2007 Feb 27.
9
Development and validation of a new high-performance liquid chromatography method for the determination of gliclazide and repaglinide in pharmaceutical formulations.一种用于测定药物制剂中格列齐特和瑞格列奈的新型高效液相色谱法的开发与验证
J AOAC Int. 2006 Mar-Apr;89(2):319-25.
10
A bioequivalence study of gliclazide based on quantification by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry.基于高效液相色谱-电喷雾串联质谱法定量的格列齐特生物等效性研究
Int J Clin Pharmacol Ther. 2007 Mar;45(3):175-85. doi: 10.5414/cpp45175.

引用本文的文献

1
Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.用于治疗糖尿病的基于脂质的格列齐特纳米粒:制剂、药代动力学、药效学和亚急性毒性研究。
Int J Nanomedicine. 2020 Feb 18;15:1129-1148. doi: 10.2147/IJN.S235290. eCollection 2020.
2
Fabrication of Second Generation Smarter PLGA Based Nanocrystal Carriers for Improvement of Drug Delivery and Therapeutic Efficacy of Gliclazide in Type-2 Diabetes Rat Model.第二代智能 PLGA 纳米晶载体的制备用于改善格列齐特在 2 型糖尿病大鼠模型中的药物传递和治疗效果。
Sci Rep. 2019 Nov 22;9(1):17331. doi: 10.1038/s41598-019-53996-4.
3
A supercritical fluid chromatography/tandem mass spectrometry method for the simultaneous quantification of metformin and gliclazide in human plasma.
一种用于同时定量测定人血浆中二甲双胍和格列齐特的超临界流体色谱/串联质谱法。
Indian J Pharm Sci. 2010 Jan;72(1):50-7. doi: 10.4103/0250-474X.62231.
4
Gliclazide microcrystals prepared by two methods of in situ micronization: pharmacokinetic studies in diabetic and normal rats.两种原位微化方法制备的格列齐特微晶:糖尿病和正常大鼠的药代动力学研究。
AAPS PharmSciTech. 2010 Jun;11(2):786-92. doi: 10.1208/s12249-010-9441-9. Epub 2010 May 5.
5
Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats.益生菌预处理降低了健康大鼠体内格列齐特的渗透(体外实验),但在糖尿病大鼠中却将其提高到未治疗健康大鼠的水平。
Arch Drug Inf. 2008 Jul;1(1):35-41. doi: 10.1111/j.1753-5174.2008.00006.x.
6
The influence of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes.3α,7α-二羟基-12-酮-5β-胆烷酸对糖尿病大鼠模型中格列齐特药代动力学及血糖水平的影响
Eur J Drug Metab Pharmacokinet. 2008 Jul-Sep;33(3):137-42. doi: 10.1007/BF03191110.
7
Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats.益生菌治疗可降低糖尿病大鼠的血糖水平,并增加格列齐特的全身吸收。
Eur J Drug Metab Pharmacokinet. 2008 Apr-Jun;33(2):101-6. doi: 10.1007/BF03191026.